Keyword: Francis Crick Institute
Inhibiting the TFAP2C protein that's responsible for degrading the extracellular matrix could help stop cancer metastasis, scientists have found.
Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.
A team of scientists clarified the role of the protein LRRK2 in tuberculosis, suspecting that it behaves similarly in Parkinson's.
Two new research insights might help make checkpoint inhibition an effective option for many more lung cancer patients.
The past week ushered in discoveries related to high cholesterol, acute myeloid leukemia and age-related memory loss.
Scientists used stem cells and assisted reproduction to create healthy offspring from genetically infertile mice.
Cancer Research UK and London investment firm Syncona have joined forces to fund and launch a new neoantigen-focused lung cancer biotech.
A new microfluidic tool could be used to duplicate within a laboratory the physiochemical environment needed to develop embryonic stem cells into organized tissue.